Publications by authors named "Judith Currier"

Claim this Profile
C
Clonal Hematopoiesis and Major Adverse Cardiac Events in People With HIV: Insights From the REPRIEVE Trial.
Liying Xue, Romit Bhattacharya, Md Mesbah Uddin, Tetsushi Nakao, Roger Zou, Judith S Currier

Arterioscler Thromb Vasc Biol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How HIV research drives health innovation in multiple diseases.
Lawrence Corey, Jirair Ratevosian, Chris Beyrer, Judith Currier, Joseph Eron

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectiveness.
Sujata E Tewari, Risa Hoffman, Shahin Lockman, Clare F Flanagan, Karen A Webb, Judith Currier

J Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVE.
Aya Awwad, Christopher de Filippi, Heather Ribaudo, Markella V Zanni, Carl J Fichtenbaum, Judith S Currier

J Am Heart Assoc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Low Dose Methotrexate on Arterial Inflammation in Persons Living with Human Immunodeficiency Virus. A double-blind randomized placebo-controlled pilot trial.
Ahmed Tawakol, Heather Ribaudo, Ashley McKhann, Jamie W Bellinge, Hadil Zureigat, Judith S Currier

J Nucl Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV.
Kristine M Erlandson, Ashley McKhann, Douglas W Kitch, Frank J Palella, Ronald J Ellis, Judith S Currier

AIDS· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIV.
Márton Kolossváry, Irini Sereti, Markella V Zanni, Carl J Fichtenbaum, Judith A Aberg, Judith S Currier

J Clin Invest· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial.
Marissa R Diggs, Sarah M Chu, Kathleen V Fitch, Maxine Olefsky, Maya G Watanabe, Judith S Currier

AIDS· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin Effects on Pericoronary Adipose Tissue Density in People With HIV: Insights From the REPRIEVE Trial.
Borek Foldyna, Ibrahim Hadzic, Thomas Mayrhofer, Júlia Karády, Jana Taron, Judith S Currier

JACC Cardiovasc Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trial.
Christopher deFilippi, Aya Awwad, Gerald S Bloomfield, Isabelle R Weir, Heather Ribaudo, Judith S Currier

AIDS· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process.
Chloe Orkin, Amy Paterson, Alexa Elias, Melanie Smuk, Kyle Ring, Judith Currier

Lancet HIV· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV.
Kristine M Erlandson, Ariela R Orkaby, Triin Umbleja, Heather J Ribaudo, Todd T Brown, Judith S Currier

JACC Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy.
Rinki Deo, Manish C Choudhary, Owen T Glover, Rachel Bender Ignacio, Julie Boucau, Judith S Currier

Open Forum Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Assessment in a Global CVD Prevention Cohort of People with HIV by PCE, PREVENT, and SCORE2.
Steven K Grinspoon, Sophia Zhao, Esteban Martinez, Carl J Fichtenbaum, Sarah M Chu, Judith S Currier

Clin Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US.
Pamela P Pei, Michelle Jones, Ruitian Hu, Wanyi Chen, Paul E Sax, Judith S Currier

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis.
Carl J Fichtenbaum, Carlos D Malvestutto, Maya G Watanabe, Emma Davies Smith, Heather J Ribaudo, Judith S Currier

Lancet HIV· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence of pitavastatin effect on muscle area or density among people with HIV.
Kristine M Erlandson, Triin Umbleja, Heather J Ribaudo, Michael T Lu, Jana Taron, Judith S Currier

AIDS· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial.
Mark J Giganti, Kara W Chew, Carlee Moser, Joseph J Eron, Mauricio Pinilla, Judith S Currier

Contemp Clin Trials· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Plaque, Inflammation, Subclinical Myocardial Injury, and Major Adverse Cardiovascular Events in the REPRIEVE Substudy.
Michael T Lu, Heather J Ribaudo, Sara McCallum, Markella V Zanni, Christopher deFilippi, Judith S Currier

JACC Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIV.
Rupak Shivakoti, Mark J Giganti, Michael M Lederman, Rachel Ketchum, Sean Brummel, Judith S Currier

J Acquir Immune Defic Syndr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIV.
Grace L Kulik, Triin Umbleja, Todd T Brown, Heather J Ribaudo, Steven K Grinspoon, Judith S Currier

Open Forum Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial.
Michael J Corley, Maya Watanabe, Alina P S Pang, Varun B Dwaraka, Ryan Smith, Judith S Currier

Clin Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial.
Marissa R Diggs, Triin Umbleja, Sara McCallum, Markella V Zanni, Sarah M Chu, Judith S Currier

Lancet HIV· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort.
Emma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, Carl J Fichtenbaum, Judith A Aberg, Judith S Currier

Open Forum Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIV.
Steven K Grinspoon, Maya Watanabe, Heather J Ribaudo, Gerald S Bloomfield, Carl J Fichtenbaum, Judith S Currier

Clin Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis